Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent LeasesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Biofrontera (BFRIW) Finished Goods (2024 - 2025)

Biofrontera has reported Finished Goods over the past 2 years, most recently at $1.4 million for Q4 2025.

  • Quarterly results put Finished Goods at $1.4 million for Q4 2025, down 78.54% from a year ago — trailing twelve months through Dec 2025 was $1.4 million (down 78.54% YoY), and the annual figure for FY2025 was $1.4 million, down 78.54%.
  • Finished Goods for Q4 2025 was $1.4 million at Biofrontera, down from $6.6 million in the prior quarter.
  • Over the last five years, Finished Goods for BFRIW hit a ceiling of $6.6 million in Q4 2024 and a floor of $1.4 million in Q4 2025.